What is Unipack?
Unipack LLC is a specialized manufacturer of over-the-counter medications, operating under stringent Good Manufacturing Practices (cGMP) and FDA compliance. The company provides comprehensive contract manufacturing and packaging services for a diverse range of products, including suppositories, topical creams, and ointments. Unipack collaborates with major U.S. retailers, focusing on enhancing operational practices to deliver affordable medication solutions and offering private label options for national brand equivalent store products across various categories.
How much funding has Unipack raised?
Unipack has raised a total of $524K across 2 funding rounds:
Debt
$150K
Debt
$374K
Debt (2020): $150K with participation from PPP
Debt (2021): $374K led by PPP
Key Investors in Unipack
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Unipack?
The recent major strategic investment signals a period of potential expansion and operational enhancement for Unipack LLC. This infusion of capital is likely to support the scaling of its contract manufacturing capabilities, potentially enabling the company to take on larger contracts or invest in advanced production technologies. Furthermore, the strategic nature of the financing suggests a focus on strengthening partnerships with key retailers and potentially broadening its private label offerings, solidifying its position as a reliable provider of affordable OTC medications.
See full Unipack company page